Illovo Sugar (Malawi) plc (MAL:ILLOVO)

Sage Therapeutics Income Statement

Financials in millions MWK. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Revenue	313,689	272,457	186,642	163,259	146,953
Revenue Growth (YoY)	15.13%	45.98%	14.32%	11.10%	13.32%
Cost of Revenue	173,955	131,774	106,992	90,773	95,393
Gross Profit	139,734	140,683	79,650	72,486	51,560
Selling, General & Admin	56,036	58,760	40,145	40,545	43,423
Operating Expenses	56,036	58,760	40,145	40,545	43,423
Operating Income	83,698	81,923	39,505	31,941	8,137
Interest Expense	-3,574	-2,973	-1,707	-3,496	-4,626
Interest & Investment Income	207	2,703	369	171	50
Currency Exchange Gain (Loss)	-24,372	123	311	722	724
Other Non Operating Income (Expenses)	-	1	-	-	-
Pretax Income	55,959	81,777	38,478	29,338	4,285
Income Tax Expense	33,327	25,019	11,848	8,869	1,546
Net Income	22,632	56,758	26,630	20,469	2,739
Net Income to Common	22,632	56,758	26,630	20,469	2,739
Net Income Growth	-60.12%	113.14%	30.10%	647.32%	-72.84%
Shares Outstanding (Basic)	713	713	713	713	713
Shares Outstanding (Diluted)	713	713	713	713	713
EPS (Basic)	31.72	79.55	37.33	28.69	3.84
EPS (Diluted)	31.72	79.55	37.33	28.69	3.84
EPS Growth	-60.12%	113.14%	30.10%	647.32%	-72.84%
Free Cash Flow	-6,367	87,517	28,834	23,842	17,373
Free Cash Flow Per Share	-8.92	122.67	40.41	33.42	24.35
Dividend Per Share	5.000	29.200	21.000	18.000	2.000
Dividend Growth	-82.88%	39.05%	16.67%	800.00%	300.00%
Gross Margin	44.55%	51.63%	42.68%	44.40%	35.09%
Operating Margin	26.68%	30.07%	21.17%	19.56%	5.54%
Profit Margin	7.22%	20.83%	14.27%	12.54%	1.86%
Free Cash Flow Margin	-2.03%	32.12%	15.45%	14.60%	11.82%
EBITDA	100,638	88,511	46,324	38,122	14,973
EBITDA Margin	32.08%	32.49%	24.82%	23.35%	10.19%
D&A For EBITDA	16,940	6,588	6,819	6,181	6,836
EBIT	83,698	81,923	39,505	31,941	8,137
EBIT Margin	26.68%	30.07%	21.17%	19.56%	5.54%
Effective Tax Rate	59.56%	30.59%	30.79%	30.23%	36.08%

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.